Recent research in the vaccine and immunotherapy fields has revealed that biomaterials have the ability to activate immune pathways, even in the absence of other immune-stimulating signals.
| I N T R O D U C T I O N
Biomaterials have enabled advances in fields spanning tissue engineering, drug delivery, vaccination and immunotherapies, and implantable devices. This breadth is due to the ability of these materials to encapsulate and protect cargos (e.g., chemicals, cells, and proteins), to provide biocompatible supports (e.g., devices, scaffolds), and to allow facile modification of chemical and physicochemical properties.
1,2 Not surprisingly, biomaterials range from naturally occurring biological building blocks to fully synthetic substances. This ever-expanding use of biomaterials is also creating increasing need for deeper understanding of the interactions between materials and the biological environments they encounter. Nowhere is this need more evident than the immune engineering field. Biomaterials are being widely explored in vaccines and immunotherapies to combat infectious disease, cancer, and autoimmunity, but the early clinical successes of these approaches are few and far between. One of the interesting findings in the field-described in seminal papers published less than a decade ago 3, 4 -is that many biomaterials exhibit intrinsic material properties that can activate immune pathways. This is certainly an analyze how these concepts might be exploited for tissue engineering and regenerative medicine. We begin with a brief introduction to the immune system and the response to injury and implanted materials.
Next, we discuss what is known about how immune response is
impacted by biomaterial properties such as size, shape, and stability/ molecular weight, along with surface features such as chemical functionality, charge, and hydrophobicity ( Figure 1 ). Then, we describe how the introduction of biomaterial scaffolds, and the specific features of these tissue engineering constructs exhibit intrinsicly immunogenic features that can impact immune cell polarization and wound healing.
Finally, we highlight new research directions leveraging the intrinsic properties of materials to control immune function and push the forefront of tissue engineering and regenerative medicine.
| I M M U N E P A T H W A Y S A C T I V A T E D BY P A T H O G E NS AN D O T H E R F O RE I G N M O L EC UL E S A LSO R ES PON D T O B IO M A T E RI A L S
Across vaccines, immunotherapies, and tissue engineering, the immune system represents both an opportunity for and barriers against successful outcomes. To protect the body from harmful pathogens, the immune system has evolved over time to quickly recognize pathogens or other non-self agents through general physicochemical features that are uncommon in the body. These include the particulate nature of bacteria and viruses, repetitive molecular patterns such as the polysaccharides that comprise bacterial cell walls, and structural motifs such as hydrophobic regions or double stranded RNA often found in molecules from viruses and bacteria. 5, 6 One component of the innate immune system-the segment that provides rapid, but less specific immune responses-are pattern-recognition receptors (PRRs). PRRs are present on antigen presenting cells (APCs), including dendritic cells (DCs) and macrophages, that scan the body for danger-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs). 7, 8 PRRs, including toll-like receptors (TLRs) and the inflammasome, identify specific DAMPs and PAMPS and initiate different signaling pathways leading to the clearance of potentially harmful agents. 9, 10 The inflammasome is a cytoplasmic complex of proteins which activates caspases and the release of IL-1b, a key cytokine involved in initiating inflammatory processes. 9, 10 Interestingly, the inflammasome has been associated with immune cell activation in response to treatment with adjuvants, materials commonly added to vaccine formulations to increase immunogenicity or potency. One ubiquitous example is alum, an FDA-approved adjuvant consisting of particulate aluminum salt formulations. [9] [10] [11] Since many existing vaccines use alum, and numerous technologies involving microparticles and nanoparticles are in development as vaccines and immunotherapies, continued research into how these materials activate the inflammasome is of great interest. The complement system is another mechanism of the immune system, consisting of serum proteins that assemble after encountering microbes or other extracellular pathogens. These proteins form complexes that tag, destroy, and eliminate the invading pathogens. antigen-experienced APCs and naïve B and T cells. Many vaccines rely on particle size or drainage through the lymphatics to provide a pathway from peripheral injection sites to the lymph nodes. [47] [48] [49] [50] [51] Past studies have shown particles with diameters between 20 and 50 nm can passively drain through lymphatics, and larger particles are more dependent on phagocytosis by APCs which carry the engulfed cargo to lymph nodes. 47, 48 The phenomena occur because particle trafficking is driven in part by the pressure gradient that exists between the blood and lymphatic vessels, causing convective forces that propel smaller particles into lymphatic vessels. [47] [48] [49] As particle size increases, particles flow at much slower rates due to steric hindrance in the interstitial space, or mechanical size limitation for micron-size particles. These larger particles are thus more reliant on internalization and trafficking by APCs to reach lymph nodes. [47] [48] [49] Thus, the size of particles used to deliver vaccines and immunotherapies plays a large role in the uptake, trafficking, and retention of the cargo and carrier in immune cells and tissues. [52] [53] [54] While particle size impacts trafficking and can alter how much carrier, drug, or vaccine reaches lymph nodes, changes in particle size also play a major role in modulating immune response. For example, with the same antigens and adjuvants present in a material-based vaccine, the size of these particles biases the interaction with innate immune cells and skews the type of antibodies produced. [55] [56] [57] In one recent study, gold nanoparticles with diameters of 3 and 12 nm were incubated with human-derived DCs. These sizes caused different levels of DC activation, as indicated by common surface maturation markers (e.g., CD80, CD83, CD86, and MHCII) and inflammatory cytokine secretion. 58 While both sizes of particles activated DCs, 3 nm particles caused higher activation levels and greater secretion of IL-12 and IFN-g. These effects translated to increased pro-inflammatory T cell function during co-culture. 58 In contrast, treatments with the 12 nm particles increased IL-4 production, skewing the resulting T cellmediated immune responses toward a different function, wound healing. 58 In another study, macrophages treated with particles of varying sizes induced different effects on the levels of the anti-inflammatory cytokine IL-10 and the pro-inflammatory cytokine TNF-a. 59 While the largest particles did not induce cytokines, smaller particles with diameters ranging from 2 to 40 mm induced size-dependent production of IL-10 and TNF-a; this activation was also shown to involve TLR-2 stimulation. 59 Many tissue engineering approaches involve implantation of macroscopic scaffolds or devices that degrade, release fragments, or experience wear effects. 15 Thus, particulates can be generated that also trigger the same size-dependent modulatory immune pathways. 15 Additionally, bulk wear or fracture of implantable devices or scaffolds is often a key design focus since this can lead to acute device failure.
From an immunological perspective, however, the inflammatory profile of the nano-and micro-scale wear products or particles will take on an emerging roll in tailoring immune responses to improve device or implant performance.
| Immune activation is influenced by biomaterial shape
While size is an important feature in determining trafficking, uptake, and intrinsic immunogenicity, the shape of materials also impacts these responses. 57, [60] [61] [62] [63] For example, in one study, gold nanorods were internalized by macrophages at greater levels than nanospheres owing to preferential uptake of the former via micropinocytosis. 64 In a separate study, glass rods were used as a tool to assess shape dependence by incubating rods of varying lengths with macrophages. 65 Short rods were more rapidly taken up than longer rods, but interestingly, the longer rods, while not readily phagocytosed, induced greater levels of the inflammatory signals IL-1a and TNF-a. 65 This inflammatory response was attributed to "frustrated" phagocytic interactions, a phenomenon that occurs when cells are unable to phagocytose larger-scale objects.
This failure results in the production of reactive oxygen species and inflammatory cytokines which ultimately could lead to chronic inflammation and fibrosis. 65 This shape effect might also be important in the context of scaffolds and implants since these constructs are commonly too large for engulfment and often shed long fibers or other geometries upon degradation or wear. Other work has studied shape effects using titanium dioxide to prepare particles with diameters of 7-10 nm (anatase) or 15-20 nm (rutile), or nanotubes with diameters of 10-15 nm and lengths of 70-150 nm. 66 These studies revealed shape dependence across cytokine secretion, production of reactive-oxygen species, and DC maturation. 66 In particular, the nanotubes generally caused the largest immunogenic effects, 66 further demonstrating that particle shape impacts immunogenicity. Later in this section, we will discuss some of the mechanistic studies beginning to ascertain how the interactions of differently shaped particles with immune cells cause these differential effects.
The extent to which the shape of particulate carriers impacts inflammasome activation is important because, while seminal work has shown particle-based carrier systems can act as adjuvants through inflammasome signaling, other work demonstrates these outcomes are not a feature of all particulate systems. 3, 4, 11, 27, 67, 68 In a study from
Vaine et al., particles synthesized from block copolymers to either exhibit rough or smooth surfaces ( Figure 2a ) differentially activated the inflammasome in mice. 69 In this study, polystyrene-polyethylene oxide particles with a rough surface morphology increased neutrophil recruitment and IL-1b secretion compared with smooth polystyrenepolyethylene oxide particles. 69 This study also found that while the particles had comparable diameters, rough particles were preferentially taken up by macrophages, leading to increased inflammasome activity that was comparable to a positive control treatment with alum. Interestingly, this activation was absent when uptake was inhibited, suggesting that phagocytosis and endosomal destabilization were needed for the materials to activate the inflammasome. 27, 69 In another study, antigen-coated gold nanostructures formed as spheres, rods, or cubes ( Figure 2b ) triggered differential levels of cytokine secretion in DCs, leading to differences in antibody production in mice. 70 The rodshaped particles induced an IL-1b (i.e., inflammasome-mediated) response, while spheres and cubes activated less specific (e.g., TNF-a) inflammatory responses. 70 These studies reveal that the inflammasome, an important pro-inflammatory signaling cascade of the innate immune system, can be manipulated simply by altering particle shape. More work is needed to understand why these effects occur with some material shapes and not others. In particular, tissue engineering uses materials spanning biological building blocks to synthetic polymers, enabling a variety of shapes and topographies. Thus, understand how these different parameters promote or diminish inflammasome activation could allow more tunable constructs.
Research from the Green and Schneck groups has focused on using polymeric particles as artificial antigen presenting cells (aAPCs), mimicking the ability of APCs such as DCs to simultaneously present antigen fragments and costimulatory markers to T cells. [71] [72] [73] In this work, the authors studied the impact of aAPC shape on T cell response. [71] [72] [73] Spherical PLGA nanoparticles were first synthesized, then mechanically stretched to form elongated, ellipsoidal particles with different aspect ratios ( Figure 2c ). To properly mimic the way natural APCs interact with T cells, both antigen and costimulatory molecules need to be presented in the correct contexts to promote T cell activation and proliferation. To accomplish this, antigen within MHC molecules along with a co-stimulatory antibody (anti-CD28) were coupled to the surface of either spherical or ellipsoidal particles to form the biomimetic aAPCs. [71] [72] [73] Since aAPCs need to interact with T cells, the parameters to ensure they remain extracellular were explored by incubating both spherical and ellipsoidal particles with macrophages and human umbilical cord vein endothelial cells. These studies revealed spherical aAPCs were phagocytosed quicker and at higher levels compared to ellipsoidal aAPCs. 72 As a result, ellipsoidal aAPCs injected intravenously in mice experienced increased circulation time and greater biodistribution compared to spherical formulations. Since ellipsoidal aAPCs with increased circulation time had more opportunity to interact with T cells, this shape ultimately led to increased T cell proliferation compared to spherical aAPCs. 72 Further analysis of aAPC properties revealed that the degree of stretching influenced the extent of T cell proliferation, with optimal stimulation occurring when aAPCs were stretched 2-2.5 fold, relative to the original diameter. 71, 72 One possible reason for this difference is that the ellipsoidal aAPCs allowed increased contact length with T cells, supporting increased numbers of surface-to-surface interactions. 71 Ultimately, treatment with ellipsoidal aAPCs displaying cancer antigens, in conjunction with a common cancer immunotherapy, reduced tumor burden and increased survival. The examples in this section demonstrate that micro-and nano-scale shape changes can significantly alter the interactions with immune cells, promoting either a pro-inflammatory or pro-regenerative niche.
These phenomena need to be further explored with tissue engineering constructs which exhibiting complex conformations, commonly employed to recapitulate the natural tissue the implant is replacing while allowing for multiple contact points with the cellular environment.
| Biomaterial surface features and chemical functionality impact immune recognition
As alluded to in Section 3.2, upon injection or implantation, surface features (e.g., roughness) and specific chemical moieties or properties can impact both the extent of interactions with immune cells and the immunogenicity. [74] [75] [76] [77] [78] An important aspect along these lines is the role hydrophobicity plays in intrinsic immunogenicity. 23, 79 The immune system has evolved to recognize molecules with highly hydrophobic portions as foreign, potentially dangerous materials (see Section 2). This property can thus trigger PRRs, leading to elimination. 23 In one study, gold nanoparticles functionalized with increasingly hydrophobic chemical groups ( Figure 3a) were incubated with immune cells isolated from the spleens of mice. 79 Particles with greater hydrophobicity increased gene expression of pro-inflammatory cytokines (e.g., TNF-a, IFN-g) and similar effects were observed after intravenous injection in mice ( Figure   3b ). 79 To combat the immunogenic effects of hydrophobic surfaces, and used to vaccinate mice. 86 The D stereochemistry, which is less susceptible to enzymatic degradation, led to stronger antibody responses and prolonged antigen presentation compared to the L stereotype. 86 Additionally, it was determined that when macrophages were treated with particles that contained either oxidized, reduced, or native protein antigens, the particles with native or reduced antigen were preferentially taken up in vitro, and promoted strong immune responses in mice. 87 The Fahmy Lab has used silica particles as a platform to understand how surface modification with polypeptides exhibiting different hydrophobicities and charges influence inflammasome signaling and DC activation in vitro. 88 As expected based on the discussion above in Sections 2 and 3.1, these studies determined inflammasome activation was size dependent. 88 Interestingly, however, investigation into how the surface chemistry of 300 nm particles impacted IL-1b secretion revealed that particles functionalized with amino acids of increasing hydrophobicity drove increasing IL-1b secretion (Figure 3c ). 88 Anionic particles caused the highest levels of activation, while cationic particles, shown above to activate pro-inflammatory responses, induced lower levels of IL-1b in this case. These differences were found to result from endocytic uptake and lysosomal rupture, a result supported by a reduction in IL-1b secretion when uptake was chemically inhibited. 88 When cells were treated with these particles mixed with OVA, cationic particles caused increased IFN-g production by T cells. Additionally, these elevated expression levels correlated to increasing particle hydrophobicity ( Figure 3d) . 88 Since the balance of M1 and M2 macrophages plays a major role in many tissues engineering applications, the studies in this section highlight opportunities to modulate immune cell phenotypes by altering the hydrophobicity, charge, or surface chemical func- Early research investigating how the degradation of biomaterials influenced immunogenicity centered on hyaluronic acid, an extracellular matrix glycosaminoglycan. [89] [90] [91] [92] In this work, hyaluronic acid was enzymatically degraded to form fragments of varying molecular weight, then incubated with DCs or in DC and T cell co-cultures. These experiments revealed low molecular weight hyaluronic acid (1500-5300 Da)
increased DC activation, inflammatory cytokine secretion, and T cell proliferation by triggering TLR-2 and TLR-4 signaling. [89] [90] [91] [92] Subsequent research has studied how macrophage differentiation is impacted by hyaluronic acid fragments with different molecular weights. 93, 94 In these studies, macrophages were polarized to an M1 phenotype by low molecular weight hyaluronic acid, while high molecular weight hyaluronic acid induced a M2 phenotype, preferred for tissue repair and healing. 93, 94 Our lab has investigated how the immunogenicity of synthetic polymers evolves as degradation progresses. Poly(beta amino esters) (PBAEs) provide an ideal system to address this question since these polymers are rapidly degradable and can be readily synthesized with different functionalities in a high-throughput manner. [95] [96] [97] [98] In one study investigating the effect of PBAE formulation and degradation on immunogenicity, PBAEs were formulated via Michael-addition reactions between a diamine and one of three diacrylate monomers differing in the number of carbons in the polymer backbone (e.g., 4, 6, 10 carbons) (Figure 4a ). These reactions resulted in polymers with varied starting molecular weight but similar degradation profiles (Figure 4b ). 98 These
PBAEs (PBAE-4, PBAE-6, and PBAE-10) were degraded for defined times to form distinct molecular weight ranges, then incubated with DCs in either a soluble or particulate form. In soluble form, none of the PBAE formulations activated DCs. 98 However, when condensed into a particulate form, PBAEs activated DCs in a molecular weight specific manner. PBAE-4 particles activated DCs at molecular weights corresponding to early stages of degradation (less degradation time). Meanwhile, PBAE-6 particles activated DCs after intermediate degradation times and PBAE-10 showed little to no immunomodulatory activity, with minimal activation occurring only after long degradation times. 98 Together, these results indicated that irrespective of degradation stage, 
. 97 These studies highlight the fact that materials may be nonimmunogenic or pro-inflammatory at one time point, but as the material degrades, the physicochemical properties can change in ways that alter the immunogenicity. Analogous experiments are still necessary with other common polymers (e.g., PLGA) or extracellular matrix components (e.g., collagen, hyaluronic acid, and fibronectin) that cause differential immune responses as the scaffold degrades or is reabsorbed after implantation. In the case of these bioresorbable scaffolds, it would be advantageous to choose a material whose immunogenic profile promotes a natural wound healing response, with the implanted construct first promoting inflammation and immune cell recruitment then, as the material degrades, shifting toward a regenerative microenvironment.
With the growing understanding of the intrinsic immunogenicity of materials, an important concept is the interconnected nature of these properties. For instance, changing the shape of a particle by stretching may also change the size. 71, 72 Similarly changing a functional group on the surface of a material may also change the surface charge and hydrophobicity; any of these variations might change the immune signatures of the materials. 88 Therefore, one goal of future research should be to understand the relative contributions of properties or sets of properties to modulate immune function. An alternate strategy to understanding these interactions is to mimic the attractive features of synthetic materials, but eliminate carriers completely by selfassembling immune signals into nanostructures. [101] [102] [103] [104] [105] [106] [107] [108] [109] However, all of these strategies share the same goal, to design materials-whether natural or synthetic-that better control immune function. 
| T IS S UE E N G I N E E R I N G CO N S T R U C T S E X H IB I T I N T RI N S I C I M M U N O G E NI C I T Y

| Macrophage responses to injury are influenced by the presence of acellular biomaterial scaffolds
Most tissue engineering approaches involve implants made from metallic, ceramic, or composite materials, or scaffolds comprised of synthetic materials, decellularized constructs, or extracellular matrix components. 15 These structures must be able to overcome immunological rejection, a process resulting from recognition by innate and adaptive This scaffold was then implanted at the injury site. 117 In this study, the macrophage response to an untreated injury resulted in a proinflammatory M1 phenotype, while implantation of the scaffold shifted this response to the M2 phenotype. 117 This example highlights how just the presence of a biomaterial at an injury site can shift the immune response to promote tissue repair, motivating research to tease out the mechanisms that modulate immune function to promote healing.
| Scaffold composition alters interactions with the immune system
There are a variety of biomaterials that can be used as tissue engineer- While the studies above used scaffolds prepared directly from complex tissues, other recent studies are investigating constructs formed from specific biological molecules or synthetic materials. [120] [121] [122] [123] [124] One such molecule is collagen, a protein abundant in the extracellular matrix that has been widely explored as a scaffold component. 125 During recent studies in mice, a collagen scaffold with silica integrated between the collagen fibers activated monocytes. These cells have the ability to differentiate into macrophages. Compared to sham surgeries, the scaffolds with silica promoted new bone and blood vessel formation. 120 The authors hypothesized this response resulted from increased IL-4 detected in serum one week after implantation; IL-4 has previously been shown to induce wound healing phenotypes. 120 Fibrin and fibrinogen have also been frequently used for tissue engineering applications; both of these proteins play a crucial role in the formation of blood clots during normal response to injury. 7, [15] [16] [17] One study investigating the effect of fibrin and fibrinogen found that thin films of fibrin promoted macrophage secretion of anti-inflammatory IL-10, and were able to reverse the secretion of inflammatory cytokines (e.g., IFN-g) from macrophages stimulated with a TLR4 agonist. 121 In contrast, soluble fibrinogen increased the pro-inflammatory cytokine, TNF-a. Interestingly, when macrophages were co-treated with both fibrin films and soluble fibrinogen, fibrin played a dominate role, resulting in an antiinflammatory response. 121 In a separate study, fibrinogen was prepared as a porous scaffold and the immunomodulatory effects on immune cells were investigated during a bone injury model. After implantation in mice, the fibrinogen scaffold outperformed sham implantations, promoting bone regrowth. These improvements were correlated with altered cytokine gene expression and changes in both the local and systemic immune cell responses. 122 Similarly, other studies have investigated synthetic ceramic materials. These studies have revealed that treatment with a clinical standard for ceramic implants (tricalcium phosphate-hydroxyapatite) promotes an M1 macrophage phenotype. 123 Alternatively, treatment with scaffolds formed from newer ceramic materials (e.g., baghdadite and strontium-hardystonite-gahnite) induced greater expression of markers indicative of M2 macrophage phenotypes. 123 Last, synthetic polymers have also played a large role as scaffold materials. One recent example demonstrates that nondegradable polypropylene meshes induced M1 macrophages, while meshes coated with dermis or urinary bladder extracellular matrix components promote M2 macrophages. 124 After implantation in rats, the meshes coated with extracellular matrix components also decreased the number of foreign body cells, a signal that a fibrous capsule would not form around the implant. 124 These studies highlight how even with 4.3 | Physicochemical properties of tissue engineering constructs also alter intrinsic immunogenicity
As with particle based delivery systems, the physicochemical properties of materials used in scaffolds can dramatically impact the interactions with the immune system. While this vein of research has garnered interest for particulate systems (see Section 3), interest in the tissue engineering field is just arising over the past few years. New studies are investigating how shape, composition, and charge of tissue engineering constructs impact the immune response. [126] [127] [128] [129] [130] [131] For example, polymeric scaffolds have been synthesized by electrospinning polycaprolactone, then the resulting fibers were modified to exhibit different shapes. 126 Scaffolds were then formed from either the random or aligned fibers. Afterward, these scaffolds were left unmodified or expanded to exhibit macro-scale thicknesses of 3 or 10 mm. 126 Following subcutaneous implantation into rats, macrophages were able to infiltrate into scaffolds formed from randomly aligned fibers with expanded thickness of 3 or 10 mm. However, scaffolds formed from aligned fibers that were expanded to 3 mm supported greater macrophage penetration and the smallest number of giant cells, a trait the authors attributed to the gap distance between the aligned fibers. 126 In a similar study, scaffolds with varying pore sizes were formed from electrospun polydioxanone. These experiments revealed a correlation between increased pore size and a shift toward M2 function and away from M1 macrophages. 127 An ongoing question in the tissue engineering field centers on the balance between the porosity of scaffolds and the mechanical properties required for the implant. As shown above, with increased porosity and an expanded conformation, tissue engineering constructs can promote pro-regenerative environments by altering macrophage function. However, this change in scaffold structure may negatively influence mechanical strength and, in the case of tissue-mimicking implants for structural components (e.g., bone), the mechanical strength of the scaffold needs to recapitulate that of the native tissue. Thus, while scaffold shape and porosity can be exploited to promote inflammation or repair by modulating macrophage phenotype and limiting fibrosis (i.e., reducing the number of foreign body cells), there is also a need to better understand the interplay between these immunological outcomes and material properties. 126, 127 Another new avenue of research has focused on the chemical composition of scaffolds and how this influences the functions of DCs and macrophages. One study showed that calcium alginate gels promote inflammatory responses in cells and in mice by releasing calcium, a signal that increased DC activation and IL-1b secretion. 128 This work revealed the intrinsic immune function stemmed from the calcium, as gels formed with barium instead of calcium led to reduced scaffold immunogenicity. 128 Since alginate hydrogels are commonly used for tissue engineering constructs and generally use calcium as the divalent ion for crosslinking, this discovery provides evidence that even the choice of molecule for cross linking could impact the resulting immune response and thus inform which divalent molecules should be used for crosslinking hydrogels. Experiments with hyaluronic acid formed into films via electrostatic interactions with poly-L-lysine caused monocytes to secrete pro-inflammatory cytokines (e.g., IL-1b, TNF-a). 129 Interestingly, after crosslinking the hyaluronic acid with aldehyde, there was a reduction in TNF-a and IL-1b secretion and slight increases in antiinflammatory cytokines. 129 This result is in agreement with the studies discussed in Section 3.4, revealing increased activation from low molecular weight hyaluronic acid fragments; these particles might be generated as non-crosslinked scaffolds begin to degrade. However, using crosslinking, the rate of degradation and the production of low molecular weight hyaluronic acid fragments generated via degradation could be slowed. This reduction decreased the overall level of proinflammatory molecules. Other work investigated how the charge of hydrogel scaffolds impacts immunogenicity by evading foreign-body reactions. 130 In this study, zwitterionic poly(carboxybetaine methacrylate) hydrogels prepared from a carboxybetaine monomer and a carboxybetaine cross-linker shifted macrophage phenotype to an anti-inflammatory state compared to samples treated with poly(2-hydroxyethyl methacrylate) hydrogels, a commonly used molecule similar to PEG that reduces protein absorption. 130 Thus, the hydrogels were able to diminished macrophage activation in mice by reducing the underlying protein adsorption to the scaffold after implantation. 130 This feature could be beneficial for future implanted biomaterial scaffolds designed to limit fibrotic buildup and implant rejection. Together, the results from this section suggest that the material with which a hydrogel is formed, the extent of crosslinking, and the molecule used for crosslinking can all impact the immunogenicity of the scaffold. Similar to the discussion in Section 3.4, there is an ongoing need to understand the interplay between these properties. For instance, if a hydrogel is formed from a material that is immunostimulatory as it degrades, crosslinking of this scaffold with calcium may result in reduced immunogenicity by reducing the degradation but could also cause a local increase in pro-inflammatory cytokines. Therefore, it will be crucial for future tissue engineering approaches to understand which properties of hydrogels are the main drivers of this intrinsic immunogenicity.
In an elegant study by Christo et al., complex surface nanotopography and chemical composition commonly seen in tissue engineering constructs were mimicked to test the impact on the response of innate immune cells. 131 Glass cover slips were coated with gold nanoparticles exhibiting varying diameters. These materials were then modified by deposition of allylamine (AA), octadiene (OD), or acrylic acid (AC) to create surfaces abundant in either amino, alkyl, or carboxylic acid groups, respectively (Figure 6a) . 131 Because the surfaces were formed with nanoparticles of varying diameters, these constructs mimicked scaffolds with either smooth surfaces or exhibited tunable degrees of surface roughness (Figure 6b ). 131 When neutrophils were incubated with the surfaces, rough and, in particular, acidic surfaces increased section of MMP-9, a protein involved in extracellular matrix 
| N E W TE C H N O L O G I E S AN D A N A L Y S I S M E T H O D S WI L L EX P L O I T I N T R I N S I C IMMUNOGENICITY TO ADVANCE TISSUE E N G I N E E R I N G CA P A B I L IT I E S
Recent studies in tissue engineering investigating the impact of material properties on immune activation have yet to fully elucidate the mechanism through which this activation occurs. Future research endeavors will need to incorporate more experimental parameters and higher, more complex animal models to determine the biomaterial features that contribute the most to immunogenicity. In one such study from the Langer and Anderson labs, mouse, rat, and non-human primate models were used to investigate how the size and shape of various biomaterial implants fabricated from ceramics, hydrogels, metals, and plastics activated innate cells and led to fibrosis. 132 First, alginate particles were prepared with sizes from 0.3 to 1.9 mm, then implanted in mice. 132 Following implant retrieval after 2 weeks, particles size was inversely correlated with expression of genes involved in fibrosis:
a-SMA (Figure 7a , left), collagen 1a1 (Figure 7a , center), and collagen 1a2 (Figure 7a , right). 132 After determining that size impacted the foreign body response to alginate, the authors compared the response to different biomaterials exhibiting similar sizes. Particles with a diameter of 0.5 mm were formulated from alginate, stainless steel, glass, polycaprolactone, or polystyrene, then implanted intraperitoneally in mice.
The implants were removed after 14 days, and all resulted in fibrotic growth (Figure 7b, top) . 132 Interestingly, particles fabricated from the same materials but with larger diameters (1.5-2 mm) reduced fibrotic tissue formation (Figure 7b , bottom), a phenomena attributed to reduced infiltration of macrophages and neutrophils at the implant site. 132 Further investigation with alginate particles of medium (0.5 mm) and large (1.5 mm) sizes implanted into non-human primates resulted in similar findings. 132 After implantation of both medium (0.5 mm) and large (1.5 mm) particles into mice, the number of neutrophils and macrophages on the excised particle as well as macrophage phenotype was determined at various times post-implantation (e.g., day 1, 4, and 7). 132 Larger particles caused a shift toward immune regulatory and wound healing macrophage phenotypes, while medium particles biased responses toward inflammatory phenotypes. 132 In another study from the Anderson lab, the mechanism through which fibrosis occurred after implantation of alginate spheres was determined. 133 This study incorporated both mouse and primate models to study the response to the implanted particles. While implantation of alginate spheres increased the macrophage, neutrophil, and B cell responses to the implants, macrophages and not neutrophils were determined to be the main cell type that drives fibrosis. 133 Using knock out mice for neutrophils, macrophages, and B cells, it was determined that macrophages were essential for the formation of fibrosis on the alginate spheres and lead to B cell recruit which further promoted fibrosis. 133 High throughput gene expression analysis revealed colony stimulating factor-1 receptor was ultimately the driving mechanism for fibrosis in response and direct inhibition of this receptor was able to control fibrosis without the complete depletion of macrophage function. 133 These studies highlight the utility of using multiple animal models and emerging technologies to determine how specific physicochemical properties influence immune responses to tissue engineering constructs. Such approaches could provide a generalizable framework for other materials and questions.
Other recent research has focused not just on innate immunity, but on the role of implanted materials in modulating adaptive immunity. In a study by the Elisseeff and Pardoll labs, scaffolds were derived from bone (B-ECM) and cardiac muscle (C-ECM) extracellular matrix components, then used to treat critical muscle injuries in mice. 134 The response to these scaffolds was compared to collagen scaffolds and saline treatments to study the underlying immune mechanisms. 134 In a normal immune response to a pathogen, APCs such as macrophages and DCs present antigen to naïve, CD3 1 T cells which then proliferate and, depending on the signals also delivered to the T cell, differentiate into various T cell subsets. 7 These subsets consist of cytotoxic CD8 (Figure 8a ). 134 When repeating these treatments in Rag1 2/2 mice, which are deficient in mature B and T cells, IL-4 gene expression was decreased to levels comparable to saline treatments, further supporting the hypothesis that T cells were responsible for IL-4 production. 134 Additional studies showed the increase in IL-4 expression was present in both the draining (e.g., inguinal) and distal lymph nodes (e.g., axillary, brachial) (Figure 8b ), indicating local changes to immune function can lead to systemic responses. 134 When mice deficient in CD4 1 T cells were used, this response was diminished, although not as low as measured when both B and T cells were knocked out in Rag1 2/2 mice (Figure 8b ). 134 These results suggest T H 2 cells play a critical role in wound healing and creating a regenerative microenvironment, while other adaptive immune cells (e.g.,
CD8
1 T cells, B cells) may play a supporting role in these processes. 134 While the majority of research in tissue engineering has focused on the innate immune cells (e.g., macrophages) that play a major role in both regeneration and in scaffold failure, this study reveals the need for B cells impact a host reaction to implanted materials, future constructs could be designed with materials that control these pathways.
As the field of tissue engineering and regenerative medicine progresses, novel biomaterials and scaffold preparation methods will motivate further studies to investigate the immunogenicity of these new materials. One exciting avenue of research is 3-D printing of tissue engineering constructs. [135] [136] [137] [138] These new approaches allow for the synthesis of implants with precise shapes and architectures fabricated from a variety of materials. In a recent study from Kang et al., biodegradable polymers and hydrogels encapsulating cells were printed together in human-scale and tissue shape-mimicking constructs. 139 This system allowed mixing of polycaprolactone with hydrogels consisting of gelatin, fibrinogen, hyaluronic acid, and glycerol to create stable structures with various pore sizes. 139 Scaffolds prepared in this way supported high viability of implanted cells and promoted tissue reconstruction for a variety of tissues types, including bone, cartilage, and muscle. 139 While this research presents a new, flexible system to synthetically create biomaterial-based scaffolds, the researchers note that the host immune response to their new materials was not investigated. 139 This comment highlights some of the broader issues facing the field, in particular, that systematic studies will be important to fully understand the mechanisms through which the immune system is activated and interacts with these constructs during wound healing and regenerative processes. LITERATURE CITED
